As healthcare costs continue to rise, there will be increased scrutiny over the true “value” of new medications for patients. Cost comparisons between individual drugs based solely on ingredient cost are no longer valid. Instead, doctors, patients, and insurance companies should consider the total cost consequence of individual therapies. Effective migraine care requires designing a successful treatment plan which includes tracking and using medication appropriately while modifying lifestyles and behaviors.
—Vijay N. Joish, PhD, Research Assistant Professor, and Diana I. Brixner, RPh, PhD, Associate Professor and Chair, Department of Pharmacotherapy, College of Pharmacy, Pharmacotherapy Outcomes Research Center, University of Utah. Salt Lake City, UT
Updated June 2008 from Headache, the Newsletter of ACHE, Spring 2005, Volume 16, Issue 1.